Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Anti-Infective Agents
  4. Volume 23, Issue 1
  5. Article
Volume 23, Issue 1
  • ISSN: 2211-3525
  • E-ISSN: 2211-3533

Abstract

Resistance to antifungals is one of the natural protection processes developed by fungi to promote their persistence. Exposure of fungi to these agents over long periods due to improper prescription or a contaminated environment increases the resistance problem. Microbiology related to fungal species and clinical settings related to the therapeutic failure of antifungal drugs are two concepts used to define resistance. The minimum inhibitory concentration (MIC) measurement is the common criterion for determining antifungal resistance. spp. is the most common group of fungi that has developed resistance to different antifungal agents. has shown resistance to numerous antifungal agents from this genus, followed by non-albicans (NAC). The majority of resistance is to the azole group of antifungal agents through various mechanisms. Resistance to echinocandins is also reported in many species of , while resistance to polyene has been observed in rare cases. The mechanism of resistance action is generally related to a genetic mutation, which changes the mechanisms of diffusion, fungal structure, and drug degradation. Biofilm formation also contributes to antifungal resistance. Current information on the nature and mechanism of antifungal resistance in spp. is briefly presented in this review.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/aia/10.2174/0122113525309478240528081719
2024-06-24
2025-01-28

  • From This Site

    /content/journals/aia/10.2174/0122113525309478240528081719
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. CiureaC.N. KosovskiI.B. MareA.D. TomaF. Pintea-SimonI.A. ManA. Candida and candidiasis-opportunism versus pathogenicity: A review of the virulence traits.Microorganisms20208685710.3390/microorganisms806085732517179
     [Google Scholar]
  2. HameedA.R. AliS.M. AhmedL.T. Biological study of Candida species and virulence factor.Int. J. Adv. Res. Eng. Technol.20181816
     [Google Scholar]
  3. MorisD.V. MelhemM.S.C. MartinsM.A. MendesR.P. Oral Candida spp. colonization in human immunodeficiency virus-infected individuals.J. Venom. Anim. Toxins Incl. Trop. Dis.200814222425710.1590/S1678‑91992008000200004
     [Google Scholar]
  4. GowN.A.R. van de VeerdonkF.L. BrownA.J.P. NeteaM.G. Candida albicans morphogenesis and host defence: Discriminating invasion from colonization.Nat. Rev. Microbiol.201210211212210.1038/nrmicro271122158429
     [Google Scholar]
  5. MoleroG. Díez-OrejasR. Navarro-GarcíaF. MonteolivaL. PlaJ. GilC. Sánchez-PérezM. NombelaC. Candida albicans: Genetics, dimorphism and pathogenicity.Int. Microbiol.1998129510610943347
     [Google Scholar]
  6. DabasP.S. An approach to etiology, diagnosis and management of different types of candidiasis.J. Yeast Fungal Res.201346374
     [Google Scholar]
  7. SurainP. AggarwalN.K. Candida, a human pathogen and major types of candidiasis.Int. J. Pharm. Sci. Res.2020114167
     [Google Scholar]
  8. DadarM. TiwariR. KarthikK. ChakrabortyS. ShahaliY. DhamaK. Candida albicans - Biology, molecular characterization, pathogenicity, and advances in diagnosis and control – An update.Microb. Pathog.201811712813810.1016/j.micpath.2018.02.02829454824
     [Google Scholar]
  9. HöfkenT. Candida and candidiasis.Current Progress in Medical Mycology.ChamSpringer2013
     [Google Scholar]
  10. NobleS.M. GianettiB.A. WitchleyJ.N. Candida albicans cell-type switching and functional plasticity in the mammalian host.Nat. Rev. Microbiol.20171529610810.1038/nrmicro.2016.15727867199
     [Google Scholar]
  11. TalapkoJ. JuzbašićM. MatijevićT. PustijanacE. BekićS. KotrisI. ŠkrlecI. Candida albicans-the virulence factors and clinical manifestations of infection.J. Fungi2021727910.3390/jof702007933499276
     [Google Scholar]
  12. KadoshD. MundodiV. A re-evaluation of the relationship between morphology and pathogenicity in Candida species.J. Fungi2020611310.3390/jof601001331940968
     [Google Scholar]
  13. DeorukhkarS.C. RoushaniS. Identification of Candida species: Conventional methods in the era of molecular diagnosis.Ann Microbiol Immunol.20181100216
     [Google Scholar]
  14. FidelP.L.Jr VazquezJ.A. SobelJ.D. Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.Clin. Microbiol. Rev.1999121809610.1128/CMR.12.1.809880475
     [Google Scholar]
  15. MendlingW. BraschJ. CornelyO.A. EffendyI. FrieseK. Ginter-HanselmayerG. HofH. MayserP. MylonasI. RuhnkeM. SchallerM. WeissenbacherE.R. Guideline: Vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).Mycoses201558S111510.1111/myc.1229225711406
     [Google Scholar]
  16. LeeH. LeeD.G. Novel approaches for efficient antifungal drug action.J. Microbiol. Biotechnol.201828111771178110.4014/jmb.1807.0700230178649
     [Google Scholar]
  17. KrishnasamyL. KrishnakumarS. KumaramanickavelG. SaikumarC. Molecular mechanisms of antifungal drug resistance in Candida species.J. Clin. Diagn. Res.201812DE01DE0610.7860/JCDR/2018/36218.11961
     [Google Scholar]
  18. SheikhN. JahagirdarV. KothadiaS. NagobaB. Antifungal drug resistance in Candida species.Eur. J. Gen. Med201310254258
     [Google Scholar]
  19. PfallerM.A. Antifungal drug resistance: Mechanisms, epidemiology, and consequences for treatment.Am. J. Med.20121251Suppl.S3S1310.1016/j.amjmed.2011.11.00122196207
     [Google Scholar]
  20. SanguinettiM. PosteraroB. Lass-FlörlC. Antifungal drug resistance among Candida species: Mechanisms and clinical impact.Mycoses201558S2Suppl. 221310.1111/myc.1233026033251
     [Google Scholar]
  21. BhattacharyaS Sae-TiaS FriesBC Candidiasis and mechanisms of antifungal resistance.Antibiotics20209631210.3390/antibiotics9060312
     [Google Scholar]
  22. LeeY. PuumalaE. RobbinsN. CowenL.E. Antifungal drug resistance: Molecular mechanisms in Candida albicans and beyond.Chem. Rev.202112163390341110.1021/acs.chemrev.0c0019932441527
     [Google Scholar]
  23. ChowdharyA. MeisJ.F. Antifungal resistance in clinically significant fungi.Fungal Genet. Biol.202013910336910.1016/j.fgb.2020.10336932201127
     [Google Scholar]
  24. OrtizC TorresR Antifungal resistance and its evolution: An increasing concern.Adv Biotech & Micro201810003007
     [Google Scholar]
  25. ChaabaneF. GrafA. JequierL. CosteA.T. Review on antifungal resistance mechanisms in the emerging pathogen Candida auris.Front. Microbiol.201910278810.3389/fmicb.2019.0278831849919
     [Google Scholar]
  26. SanglardD. Resistance and tolerance mechanisms to antifungal drugs in fungal pathogens.Mycologist2003172747810.1017/S0269915X03002076
     [Google Scholar]
  27. ArastehfarA. GabaldónT. Garcia-RubioR. JenksJ.D. HoeniglM. SalzerH.J.F. IlkitM. Lass-FlörlC. PerlinD.S. Drug-resistant fungi: An emerging challenge threatening our limited antifungal armamentarium.Antibiotics202091287710.3390/antibiotics912087733302565
     [Google Scholar]
  28. PerlinD.S. Rautemaa-RichardsonR. Alastruey-IzquierdoA. The global problem of antifungal resistance: Prevalence, mechanisms, and management.Lancet Infect. Dis.20171712e383e39210.1016/S1473‑3099(17)30316‑X28774698
     [Google Scholar]
  29. BermanJ. KrysanD.J. Drug resistance and tolerance in fungi.Nat. Rev. Microbiol.202018631933110.1038/s41579‑019‑0322‑232047294
     [Google Scholar]
  30. Parente-RochaJA BailãoAM AmaralAC TabordaCP PaccezJD BorgesCL PereiraM Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: An overview about endemic dimorphic fungi.Mediat Inflamm20172017987067910.1155/2017/9870679
     [Google Scholar]
  31. Kumar NigamP. Antifungal drugs and resistance: Current concepts.Nasza Dermatol. Online20156221222110.7241/ourd.20152.58
     [Google Scholar]
  32. FisherM.C. HawkinsN.J. SanglardD. GurrS.J. Worldwide emergence of resistance to antifungal drugs challenges human health and food security.Science2018360639073974210.1126/science.aap799929773744
     [Google Scholar]
  33. Espinel-IngroffA. Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi.Rev. Iberoam. Micol.200825210110610.1016/S1130‑1406(08)70027‑518473504
     [Google Scholar]
  34. SardiJ.C.O. ScorzoniL. BernardiT. Fusco-AlmeidaA.M. Mendes GianniniM.J.S. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.J. Med. Microbiol.2013621102410.1099/jmm.0.045054‑023180477
     [Google Scholar]
  35. SudberyP.E. Growth of Candida albicans hyphae.Nat. Rev. Microbiol.201191073774810.1038/nrmicro263621844880
     [Google Scholar]
  36. NadeemS.G. ShafiqA. HakimS.T. AnjumY. KazmS.U. Effect of growth media, pH and temperature on yeast to hyphal transition in Candida albicans.Open J. Med. Microbiol.2013318519210.4236/ojmm.2013.33028
     [Google Scholar]
  37. EsfandiaryM.A. FarasatA. EostamianM. FattahyA. KoolagyM.H. EsfandiaryA. Study of morphological characteristics, pathogenicity and drug resistance of Candida glabrata as increasing opportunistic yeast.Eur. J. Exp. Biol.20122948952
     [Google Scholar]
  38. ShethC.C. JohnsonE. BakerM.E. HaynesK. MühlschlegelF.A. Phenotypic identification of Candida albicans by growth on chocolate agar.Med. Mycol.200543873573810.1080/1369378050026599816422305
     [Google Scholar]
  39. MidhatA.S. Al-AttraqchiA.A.F. Al-dinT.H. Relation of recurrent vulvovaginal candidiasis with beta defensin and IL-4 among different Iraqi women.Ann. Trop. Med. Public Health2020231410.36295/ASRO.2020.231445
     [Google Scholar]
  40. KontoyiannisD.P. LewisR.E. Antifungal drug resistance of pathogenic fungi.Lancet200235993121135114410.1016/S0140‑6736(02)08162‑X11943280
     [Google Scholar]
  41. WiederholdN. Antifungal resistance: Current trends and future strategies to combat.Infect. Drug Resist.20171024925910.2147/IDR.S12491828919789
     [Google Scholar]
  42. VazquezJ.A. Combination antifungal therapy against Candida species: The new frontier-are we there yet?Med. Mycol.200341535536810.1080/1369378031000161652814653512
     [Google Scholar]
  43. TitmarshS. Tackling the growing problem of antifungal resistance.Prescriber20182911242710.1002/psb.1718
     [Google Scholar]
  44. Vanden BosscheH. MarichalP. OddsF.C. Molecular mechanisms of drug resistance in fungi.Trends Microbiol.199421039340010.1016/0966‑842X(94)90618‑17850208
     [Google Scholar]
  45. SobelJ.D. FaroS. ForceR.W. FoxmanB. LedgerW.J. NyirjesyP.R. ReedB.D. SummersP.R. Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations.Am. J. Obstet. Gynecol.1998178220321110.1016/S0002‑9378(98)80001‑X9500475
     [Google Scholar]
  46. Ramírez-LozadaT. Espinosa-HernándezV.M. Frías-De-LeónM.G. Martínez-HerreraE. Update of vulvovaginal candidiasis in pregnant and non-pregnant patients.Curr. Fungal Infect. Rep.201913418119010.1007/s12281‑019‑00357‑3
     [Google Scholar]
/content/journals/aia/10.2174/0122113525309478240528081719
Loading
Antifungal Resistance in Candida Species: A Bit from the Totality
Anti Infect. Agents 23, E240624231252 (2025); https://doi.org/10.2174/0122113525309478240528081719
/content/journals/aia/10.2174/0122113525309478240528081719
/content/journals/aia/10.2174/0122113525309478240528081719
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): antifungal; azole; biofilm; Candida; eukaryotic nature; polyene; resistance

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test